Novavax Vax Finally Gets FDA Green Light

After weeks of waiting, Novavax’s Covid-19 vaccine just got FDA approval—but only for people 65+ or anyone 12+ with a health condition that puts them at higher risk. Unlike Pfizer and Moderna’s mRNA shots, Novavax uses a more old-school protein-based tech. The FDA wants more studies on rare heart inflammation risks, but experts say the benefits still outweigh the risks for those who need it most. Looks like there’s a new option for high-risk folks this season! #Novavax #Covid19Vaccine #FDAApproval #HealthNews #VaccineUpdate #Health